Lutetium Lu 177 Vipivotide Tetraxetan Clinical Trials
9 actively recruiting trials across 8 locations
▲ +1 trial since May 2026
Also known as: 177Lu-PSMA-617, 177Lu-labeled PSMA-617, AAA 617, AAA-617, AAA617 +5 more
Pipeline
Top Sponsors
- Jonsson Comprehensive Cancer Center2
- Janssen Research & Development, LLC2
- University of Washington1
- Mayo Clinic1
- Fred Hutchinson Cancer Center1
Indications
- Cancer9
- Stage IVB Prostate Cancer AJCC v86
- Castration-Resistant Prostate Carcinoma4
- Stage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) v81
- Metastatic Castration-Resistant Prostate Adenocarcinoma1
Los Angeles, California2 trials
UCLA / Jonsson Comprehensive Cancer Center
UCLA / Jonsson Comprehensive Cancer Center
Tucson, Arizona1 trial
Banner University Medical Center - Tucson
Duarte, California1 trial
City of Hope Medical Center
San Francisco, California1 trial
University of California San Francisco
Aurora, Colorado1 trial
University of Colorado Anschutz Medical Campus
Sarasota, Florida1 trial
Florida Cancer Specialists
Rochester, Minnesota1 trial
Mayo Clinic in Rochester
Seattle, Washington1 trial
Fred Hutch/University of Washington Cancer Consortium
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.